Legal & General Group PLC Nektar Therapeutics Transaction History

Legal & General Group PLC

$423 Billion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.64 - $3.15 $83,902 - $412,955	-131,097 Reduced 24.21%	410,332 $287,000
Q4 2022 Feb 14, 2023	BUY	$2.03 - $4.28 $28,799 - $60,720	14,187 Added 2.69%	541,429 $1.22 Million
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $284,249 - $480,605	-93,503 Reduced 15.06%	527,242 $1.69 Million
Q2 2022 Aug 22, 2022	BUY	$3.17 - $6.17 $4,520 - $8,798	1,426 Added 0.23%	620,745 $2.36 Million
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $435,864 - $1.44 Million	104,775 Added 20.36%	619,319 $3.34 Million

Q4 2021 Feb 14, 2022	BUY	$10.83 - $18.41 $2.86 Million - $4.85 Million	263,708 Added 105.13%	514,544 $6.95 Million
Q3 2021 Nov 15, 2021	BUY	$13.07 - $18.84 $443,569 - $639,391	33,938 Added 15.65%	250,836 $4.51 Million
Q2 2021 Aug 12, 2021	SELL	$16.52 - $20.4 $790,812 - $976,547	-47,870 Reduced 18.08%	216,898 $3.72 Million
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $619,625 - $952,636	-37,417 Reduced 12.38%	264,768 $5.3 Million
Q4 2020 Feb 12, 2021	SELL	$15.77 - $19.03 $365,185 - $440,677	-23,157 Reduced 7.12%	302,185 $5.14 Million
Q3 2020 Nov 13, 2020	BUY	$16.59 - $24.79 $330,721 - $494,188	19,935 Added 6.53%	325,342 $5.4 Million
Q2 2020 Aug 14, 2020	SELL	$16.86 - $23.44 $421,533 - $586,046	-25,002 Reduced 7.57%	305,407 $7.07 Million
Q1 2020 May 14, 2020	BUY	$14.47 - $27.96 $345,123 - $666,873	23,851 Added 7.78%	330,409 $5.93 Million
Q4 2019 Feb 13, 2020	SELL	$15.87 - $23.12 $6.06 Million - $8.83 Million	-381,806 Reduced 55.47%	306,558 $6.61 Million
Q3 2019 Nov 13, 2019	BUY	$16.91 - $36.27 $321,103 - $688,731	18,989 Added 2.84%	688,364 $12.5 Million
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $1.53 Million - $1.79 Million	49,373 Added 7.96%	669,375 $23.8 Million
Q1 2019 May 15, 2019	BUY	$31.58 - $46.35 $6.73 Million - $9.88 Million	213,092 Added 52.37%	620,002 $20.8 Million
Q4 2018 Feb 15, 2019	BUY	$30.43 - $56.65 $1.72 Million - $3.2 Million	56,553 Added 16.14%	406,910 $13.4 Million
Q3 2018 Nov 20, 2018	BUY	$46.46 - $68.49 $2.13 Million - $3.14 Million	45,885 Added 15.07%	350,357 $21.3 Million
Q2 2018 Aug 10, 2018	BUY	$46.25 - $104.45 $7.09 Million - $16 Million	153,270 Added 101.37%	304,472 $14.8 Million
Q1 2018 May 17, 2018	SELL	$57.4 - $108.44 $9.41 Million - $17.8 Million	-163,865 Reduced 52.01%	151,202 $16.1 Million
Q4 2017 Feb 13, 2018	BUY	$23.02 - $60.5 $7.25 Million - $19.1 Million	315,067	315,067 $18.8 Million

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

Deep Track Capital, LP Greenwich, CT

18.4M
Shares

$21.5 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$14.1 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

7.57M
Shares

$8.86 Million
0.02% of portfolio
Primecap Management CO Pasadena, CA

6.97M
Shares

$8.15 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.88M
Shares

$6.88 Million
0.0% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account